Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
US7132428B2 · kind B2 · utility
1Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2003 |
| Grant date | Nov 7, 2006 |
| Priority date | — |
| Expiry date | Dec 13, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4745
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula Iare suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.